ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,362Medicare Part D Prescriptions Filled, Including Refills

Rank: 230 out of 1206

$420K Total Retail Price of All Prescriptions

Rank: 261 out of 1206

434 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,943 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 506 411 1 2
HYDROCODONE-ACETAMINOPHEN 382 222 S3 2 7
OMEPRAZOLE 333 238 3 3
SIMVASTATIN 304 230 4 1
AMLODIPINE BESYLATE 280 220 5 6
LISINOPRIL 251 212 6 4
METFORMIN HCL 245 172 7 10
FUROSEMIDE 213 166 8 5
POTASSIUM CHLORIDE 196 156 9 12
ATENOLOL 167 119 10 14
METOPROLOL SUCCINATE 164 142 11 15
METOPROLOL TARTRATE 135 86 12 9
ALLOPURINOL 130 116 13 24
LOVASTATIN 130 121 13 44
HYDROCHLOROTHIAZIDE 127 96 15 11
CITALOPRAM HBR 123 118 16 16
MELOXICAM 115 78 17 35
PANTOPRAZOLE SODIUM 113 89 18 54
GLIPIZIDE 111 103 19 64
OXYCODONE HCL-ACETAMINOPHEN 104 30 S2 20 198
PROAIR HFA 99 82 21 49
GABAPENTIN 95 51 22 18
RANITIDINE HCL 93 45 23 23
ATORVASTATIN CALCIUM 91 86 24 13
METFORMIN HCL ER 85 72 25 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 76 26 27
ZOLPIDEM TARTRATE 83 53 26 25
LOSARTAN POTASSIUM 83 62 26 20
PRAVASTATIN SODIUM 81 48 29 21
TRAZODONE HCL 77 34 30 37
TRIAMTERENE-HCTZ 76 50 31 33
GLIPIZIDE ER 72 63 32 99
LANTUS 71 52 33 38
ROPINIROLE HCL 66 29 34 77
PREDNISONE 65 58 35 28
SERTRALINE HCL 62 54 36 22
FLUTICASONE PROPIONATE 62 36 36 42
GLIMEPIRIDE 60 48 38 34
AMITRIPTYLINE HCL 59 55 R 39 59
ALENDRONATE SODIUM 59 57 39 19
LANTUS SOLOSTAR 58 31 41 85
VERAPAMIL ER 58 46 41 97
NEXIUM 57 43 43 47
ENALAPRIL MALEATE 55 55 44 45
WARFARIN SODIUM 54 54 45 8
TRIAMTERENE-HYDROCHLOROTHIAZID 53 40 46 131
GEMFIBROZIL 53 50 46 71
TAMSULOSIN HCL 52 50 48 26
MIRTAZAPINE 52 48 48 50
TRAMADOL HCL 50 36 50 17
FLUOXETINE HCL 50 33 50 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.